Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian

Line Guenette; Véronique  Turcotte; Laurianne  Bélanger; Lucie Blais; Caroline Sirois; Carlotta  Lunghi; Polly R Duncan

doi:10.1017/S0714980822000058

Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian

Line Guenette^*
, Véronique Turcotte
, Laurianne Bélanger
, Lucie Blais
, Caroline Sirois
, Carlotta Lunghi
, Polly R Duncan

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

13 Citations (Scopus)

124 Downloads (Pure)

Abstract

Reliable treatment burden measures are needed given the aging population and the associated increase in multimorbidity and polypharmacy. Treatment burden is defined as the effort to care for one's health and the resulting impact on one's daily life.

This study aimed to translate the Multimorbidity Treatment Burden Questionnaire (MTBQ) for French-Canadians and assess its reliability and validity.

The MTBQ was translated and tested with cognitive debriefing interviews, and the French version (MTBQ-F) was then administered 2 times among 105 participants. Reliability and validity were examined using the intra-class correlation coefficient (ICC), Cronbach's alpha, and Spearman's correlations. The median global MTBQ-F scores were 32.69 (interquartile range [IQR]: 21.15-48.08) and 30.77 (IQR: 21.15-46.15) for the first and second administrations, respectively. Test-retest (ICC: 0.73; 95% CI: 0.63-0.81) and internal consistency reliability (Cronbach's alpha: 0.80) were good. There was a moderate positive correlation between the MTBQ-F score and the number of self-reported conditions (rho: 0.28).

This valid instrument could identify patients experiencing a high treatment burden and assess the impact of interventions among them.

Original language	English
Pages (from-to)	1-9
Number of pages	9
Journal	Canadian Journal on Aging / La Revue canadienne du vieillissement
Early online date	10 May 2022
DOIs	https://doi.org/10.1017/S0714980822000058
Publication status	E-pub ahead of print - 10 May 2022

Keywords

aging
multimorbidity
chronic conditions
polypharmacy
treatment burden
validation

Access to Document

10.1017/S0714980822000058

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Cambridge University Press at https://doi.org/10.1017/S0714980822000058 . Please refer to any applicable terms of use of the publisher.
Final published version, 347 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{206cefb50c82458e8787d43cdce2281b,

title = "Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian",

abstract = "Reliable treatment burden measures are needed given the aging population and the associated increase in multimorbidity and polypharmacy. Treatment burden is defined as the effort to care for one's health and the resulting impact on one's daily life. This study aimed to translate the Multimorbidity Treatment Burden Questionnaire (MTBQ) for French-Canadians and assess its reliability and validity. The MTBQ was translated and tested with cognitive debriefing interviews, and the French version (MTBQ-F) was then administered 2 times among 105 participants. Reliability and validity were examined using the intra-class correlation coefficient (ICC), Cronbach's alpha, and Spearman's correlations. The median global MTBQ-F scores were 32.69 (interquartile range [IQR]: 21.15-48.08) and 30.77 (IQR: 21.15-46.15) for the first and second administrations, respectively. Test-retest (ICC: 0.73; 95\% CI: 0.63-0.81) and internal consistency reliability (Cronbach's alpha: 0.80) were good. There was a moderate positive correlation between the MTBQ-F score and the number of self-reported conditions (rho: 0.28). This valid instrument could identify patients experiencing a high treatment burden and assess the impact of interventions among them.",

keywords = "aging, multimorbidity, chronic conditions, polypharmacy, treatment burden, validation",

author = "Line Guenette and V{\'e}ronique Turcotte and Laurianne B{\'e}langer and Lucie Blais and Caroline Sirois and Carlotta Lunghi and Duncan, \{Polly R\}",

year = "2022",

month = may,

day = "10",

doi = "10.1017/S0714980822000058",

language = "English",

pages = "1--9",

journal = "Canadian Journal on Aging / La Revue canadienne du vieillissement",

issn = "1710-1107",

publisher = "Cambridge University Press",

}

Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian. / Guenette, Line; Turcotte, Véronique ; Bélanger, Laurianne et al.
In: Canadian Journal on Aging / La Revue canadienne du vieillissement, 10.05.2022, p. 1-9.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Multimorbidity Treatment Burden Questionnaire (MTBQ)

T2 - Translation, Cultural Adaptation, and Validation in French-Canadian

AU - Guenette, Line

AU - Turcotte, Véronique

AU - Bélanger, Laurianne

AU - Blais, Lucie

AU - Sirois, Caroline

AU - Lunghi, Carlotta

AU - Duncan, Polly R

PY - 2022/5/10

Y1 - 2022/5/10

N2 - Reliable treatment burden measures are needed given the aging population and the associated increase in multimorbidity and polypharmacy. Treatment burden is defined as the effort to care for one's health and the resulting impact on one's daily life. This study aimed to translate the Multimorbidity Treatment Burden Questionnaire (MTBQ) for French-Canadians and assess its reliability and validity. The MTBQ was translated and tested with cognitive debriefing interviews, and the French version (MTBQ-F) was then administered 2 times among 105 participants. Reliability and validity were examined using the intra-class correlation coefficient (ICC), Cronbach's alpha, and Spearman's correlations. The median global MTBQ-F scores were 32.69 (interquartile range [IQR]: 21.15-48.08) and 30.77 (IQR: 21.15-46.15) for the first and second administrations, respectively. Test-retest (ICC: 0.73; 95% CI: 0.63-0.81) and internal consistency reliability (Cronbach's alpha: 0.80) were good. There was a moderate positive correlation between the MTBQ-F score and the number of self-reported conditions (rho: 0.28). This valid instrument could identify patients experiencing a high treatment burden and assess the impact of interventions among them.

AB - Reliable treatment burden measures are needed given the aging population and the associated increase in multimorbidity and polypharmacy. Treatment burden is defined as the effort to care for one's health and the resulting impact on one's daily life. This study aimed to translate the Multimorbidity Treatment Burden Questionnaire (MTBQ) for French-Canadians and assess its reliability and validity. The MTBQ was translated and tested with cognitive debriefing interviews, and the French version (MTBQ-F) was then administered 2 times among 105 participants. Reliability and validity were examined using the intra-class correlation coefficient (ICC), Cronbach's alpha, and Spearman's correlations. The median global MTBQ-F scores were 32.69 (interquartile range [IQR]: 21.15-48.08) and 30.77 (IQR: 21.15-46.15) for the first and second administrations, respectively. Test-retest (ICC: 0.73; 95% CI: 0.63-0.81) and internal consistency reliability (Cronbach's alpha: 0.80) were good. There was a moderate positive correlation between the MTBQ-F score and the number of self-reported conditions (rho: 0.28). This valid instrument could identify patients experiencing a high treatment burden and assess the impact of interventions among them.

KW - aging

KW - multimorbidity

KW - chronic conditions

KW - polypharmacy

KW - treatment burden

KW - validation

UR - https://pubmed.ncbi.nlm.nih.gov/35535517/#affiliation-1

U2 - 10.1017/S0714980822000058

DO - 10.1017/S0714980822000058

M3 - Article (Academic Journal)

C2 - 35535517

SN - 1710-1107

SP - 1

EP - 9

JO - Canadian Journal on Aging / La Revue canadienne du vieillissement

JF - Canadian Journal on Aging / La Revue canadienne du vieillissement

ER -

Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian

Abstract

Keywords

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this